Differences in the mode of action of cyclosporine and FK 506

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 959-960

  Hutchinson, I V ^a   Bagnall, W ^a   Bryce, P ^a   Pufong, B ^a   Geraghty, P ^a   Brogan, I ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CALCINEURIN; CYCLOSPORIN; CYTOKINE RECEPTOR; FK BINDING PROTEIN; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; IMMUNOPHILIN; INTERLEUKIN 2; TACROLIMUS; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG ACTIVITY; DRUG BINDING; DRUG POTENCY; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031803770     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00110-9     Document Type: Conference Paper

References (4)

1. Bram RJ, Hung DT, Martin PK, et al: Mol Cell Biol 13:4760, 1993
2. Smith DF, Toft DO: Mol Endocrinol 7:4, 1993
3. O'Shea JJ: Immunity 7:1, 1997
4. Okadome T, Oeda E, Saitoh M, et al: J Biol Chem 271:21687, 1996